Longeveron获得加拿大专利,旨在使用干细胞治疗非缺血性扩张型心肌病以及与炎症老化相关的衰弱。
Longeveron获得加拿大专利,旨在使用干细胞治疗非缺血性扩张型心肌病以及与炎症老化相关的衰弱。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.